Cardiovascular Disease Doctors in Chattanooga, TN Accepting Medicare

43 Cardiovascular Disease doctors found. Showing 41 - 43

Dr. John Carter Hemphill, MD Internal Medicine - Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 2501 Citico Ave, Chattanooga, TN 37404 Phone: 423-697-2000    Fax: 423-697-2118

Kelly R. Richardson, MD Internal Medicine - Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 2501 Citico Ave, Chattanooga, TN 37404 Phone: 423-697-2000    Fax: 423-697-2118

Dr. William P Warren, MD Internal Medicine - Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 2501 Citico Ave, Chattanooga, TN 37404 Phone: 423-697-2000    Fax: 423-697-2118

News Archive

Researchers find new technique for long-term treatment of DVT

Deep Venous Thrombosis (DVT) is a serious condition that involves the formation of a blood clot inside of a deep vein usually in the legs. A patient with DVT is typically treated with anticoagulants (blood thinners) however researchers have found that image-guided interventional radiology procedures may play a more central role in the long-term treatment of DVT, according to a study published in the October issue of the American Journal of Roentgenology (AJR).

Speech Pathology Australia raises awareness about Developmental Language Disorder

Speech Pathology Australia is driving a campaign in Australia to shed light on a hidden condition that affects on average two children in every classroom.

Johns Hopkins scientists identify protein mechanism that regulates cell division

By tracking the flow of information in a cell preparing to split, Johns Hopkins scientists have identified a protein mechanism that coordinates and regulates the dynamics of shape change necessary for division of a single cell into two daughter cells.

Dendreon requests licensure for additional capacity to manufacture PROVENGE at New Jersey facility

Dendreon Corporation today announced that it has completed the submission of the post-approval supplement to the PROVENGE® (sipuleucel-T) Biologics License Application for the Morris Plains, New Jersey manufacturing facility. Dendreon is requesting licensure for an additional 36 workstations to manufacture PROVENGE. The standard U.S. Food and Drug Administration (FDA) review for a post-approval supplement to a Biologics License Application is typically four months.

Frailty screening could help improve outcomes in older surgery patients

Identifying frailty in older patients could increase their chances of surviving surgery, as well as improve their overall outcomes, according to a new study posted online today in The Annals of Thoracic Surgery.

Read more Medical News

› Verified 9 days ago

• 1
• 2
• 3(current)